Overview


According to FutureWise analysis the market for glycomics or glycobiology in 2023 is US$ 1.89 billion, and is expected to reach US$ 5.72 billion by 2031 at a CAGR of 14.82%.

The rising research and development activities pertaining to glycomics, increased investments by biotech and pharma companies and rising demand for proteomics are some of the key factors driving the glycomics or glycobiology market growth. Furthermore, the glycoscience sector is growing rapidly and glycans are crucial in biological research and processes in understanding biology in a comprehensive manner. As per the Biotech Briefing in 2018, the average expenditure for research and development of biotechnology companies has risen by over 15% from 2016 to 2017. Furthermore, the government bodies are increasingly involved in undertaking the initiatives for conducting extensive research activities related to glycomics. For instance, the Australian government has invested over USD 10 billion for research innovations and activities during the period 2017-2018. Furthermore, the Irish government declared an expenditure of over USD 5 billion in 2015 for increasing research activities across the country. Such initiatives shall boost the growth of the market.

  • Merck KGaA
  • Agilent Technologies
  • Thermo Fisher Scientific
  • New England Biolabs
  • Shimadzu Corporation
  • Takara Bio
  • S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • Waters Corporation
  • Asparia Glycomics S.L.
  • Bio-Techne
  • Bruker Corporation
  • Danaher Corporation
  • RayBiotech
  • Z Biotech
  • Chemily Glycoscience
  • Dextra Laboratories
  • Lectenz Bio
  • Ludger Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Enzymes
    • Glycosidases
    • Neuraminidases
    • Glycosyltransferases
    • Sialyltransferases
    • Others
  • Kits
    • Glycan Labeling Kits
    • Glycan Purification Kits
    • Glycan Release Kits
    • Others
  • Reagents
    • Glycoproteins
    • Monosaccharides
    • Oligosaccharides
    • Others
  • Instruments
    • Mass Spectrometers
    • HPLC
    • MALDI-TOF
    • Array Systems
    • Others

By Application

  • Drug Discovery and Development
  • Disease Diagnostics
  • Other Applications

By End User

  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

The market is bifurcated into product, application, end user and region. The product segment is categorized into enzymes, instruments, kits, carbohydrates and reagents chemicals. The enzymes segment is predicted to hold the largest glycomics/glycobiology market share owing to the wide range of applications in diagnostics and research and increased sale of these products. The application segment is categorized into drug discovery and development, disease diagnostics and other applications. The drug discovery and development segment is predicted to lead the market and this can be credited to an increased insistence for personalized medicines and emphasis on advanced drug development. The end user segment is fragmented into academic research institutes, pharmaceutical and biotechnology companies and clinical laboratories. The pharmaceutical and biotechnology company segment is anticipated to dominate the market owing to the rise in the number of investments made by these companies for research and development of glycomics.

The North America region is expected to subjugate the market, and this can be primarily credited to increased investments in research activities pertaining to glycomics and a strong presence of key market players in the region. The Asia Pacific region, on the other hand, is predicted to grow at a substantial rate during the forecasted timeframe owing to the increased healthcare expenditure and operational expanse of biotech and pharma companies in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global glycomics/glycobiology market By product, By application, By end user and By region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Glycomics or Glycobiology Market Variables, Trends and Scope

    •   1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview

    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Glycomics or Glycobiology Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.   Glycomics or Glycobiology Market Analysis Tools

    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Glycomics or Glycobiology Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Enzymes
         1.1. Glycosidases
         1.2. Neuraminidases
         1.3. Glycosyltransferases
         1.4. Sialyltransferases
         1.5. Others
        2. Kits
         2.1. Glycan Labeling Kits
         2.2. Glycan Purification Kits
         2.3. Glycan Release Kits
         2.4. Others
        3. Reagents
         3.1. Glycoproteins
         3.2. Monosaccharides
         3.3. Oligosaccharides
         3.4. Others
        4. Instruments
         4.1. Mass Spectrometers
         4.2. HPLC
         4.3. MALDI-TOF
         4.4. Array Systems
         4.5. Others

  • 8.   Glycomics or Glycobiology Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Drug Discovery and Development
        2. Disease Diagnostics
        3. Other Applications

  • 9.   Glycomics or Glycobiology Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Academic Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Clinical Laboratories

  • 10.   North America Glycomics or Glycobiology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Glycomics or Glycobiology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Glycomics or Glycobiology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Glycomics or Glycobiology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Glycomics or Glycobiology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Merck KGaA
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Agilent Technologies
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Thermo Fisher Scientific
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. New England Biolab
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Shimadzu Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Takara Bio
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Waters Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Asparia Glycomics S.L.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Bio-Techne
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Bruker Corporation
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Danaher Corporation
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. RayBiotech
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Z Biotech
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Chemily Glycoscience
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Dextra Laboratories
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Lectenz Bio
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Ludger Ltd.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11